These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15776868)

  • 21. Oxidative stress and lymphocyte persistence: implications in immunotherapy.
    Mehrotra S; Mougiakakos D; Johansson CC; Voelkel-Johnson C; Kiessling R
    Adv Cancer Res; 2009; 102():197-227. PubMed ID: 19595310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuous presence of Th1 conditions is necessary for longer lasting tumor-specific CTL activity in stimulation cultures with PBL.
    Chattopadhyay S; Chakraborty NG
    Hum Immunol; 2005 Aug; 66(8):884-91. PubMed ID: 16216672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of CD4+CD25+ Treg on tumor specific CD8+ T cell cytotoxicity and cancer.
    Khazaie K; von Boehmer H
    Semin Cancer Biol; 2006 Apr; 16(2):124-36. PubMed ID: 16443370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential regulation of perforin expression in human CD4+ and CD8+ cytotoxic T lymphocytes.
    Niiya H; Sakai I; Lei J; Azuma T; Uchida N; Yakushijin Y; Hato T; Fujita S; Yasukawa M
    Exp Hematol; 2005 Jul; 33(7):811-8. PubMed ID: 15963857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tetanus toxoid provides efficient T-cell help for the induction of HA-1(H) cytotoxic T cells.
    Eiz-Vesper B; Horn PA; Daubert C; Khattab B; Blasczyk R
    Transfusion; 2006 Jul; 46(7):1210-20. PubMed ID: 16836569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The requirements for CTL-mediated rejection of cancer in humans: NKG2D and its role in the immune responsiveness of melanoma.
    Wang E; Selleri S; Marincola FM
    Clin Cancer Res; 2007 Dec; 13(24):7228-31. PubMed ID: 18094399
    [No Abstract]   [Full Text] [Related]  

  • 27. Presence of low dose of fludarabine in cultures blocks regulatory T cell expansion and maintains tumor-specific cytotoxic T lymphocyte activity generated with peripheral blood lymphocytes.
    Hegde U; Chhabra A; Chattopadhyay S; Das R; Ray S; Chakraborty NG
    Pathobiology; 2008; 75(3):200-8. PubMed ID: 18550918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. B7.2-Ig fusion proteins enhance IL-4-dependent differentiation of tumor-sensitized CD8+ cytotoxic T lymphocyte precursors.
    Hiraoka S; Takeuchi N; Bian Y; Nakahara H; Kogo M; Dunussi-Joannopoulos K; Wolf S; Ono S; Fujiwara H
    Int Immunol; 2005 Aug; 17(8):1071-9. PubMed ID: 16027141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clonal diversity of cytotoxic T lymphocytes that recognize autologous oral squamous cell carcinoma.
    Kobayashi J; Hirohashi Y; Torigoe T; Michifuri Y; Yamamoto T; Tamura Y; Kamiguchi K; Miyazaki A; Yamaguchi A; Hariu H; Hiratsuka H; Sato N
    Hum Immunol; 2009 Feb; 70(2):89-95. PubMed ID: 19124056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple roles for CD4+ T cells in anti-tumor immune responses.
    Kennedy R; Celis E
    Immunol Rev; 2008 Apr; 222():129-44. PubMed ID: 18363998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Function analysis of the family-specific CTL induced by peptides derived from IgHV gene framework region of B-cell malignance].
    Guo XL; Zhu P; Liu Y; Liu J; Zhu X
    Zhonghua Xue Ye Xue Za Zhi; 2005 Aug; 26(8):453-7. PubMed ID: 16383233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of CTL function among high-avidity tumor-specific CD8+ T cells following tumor infiltration.
    Janicki CN; Jenkinson SR; Williams NA; Morgan DJ
    Cancer Res; 2008 Apr; 68(8):2993-3000. PubMed ID: 18413769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ex vivo expanded human CD4+ regulatory NKT cells suppress expansion of tumor antigen-specific CTLs.
    Osada T; Morse MA; Lyerly HK; Clay TM
    Int Immunol; 2005 Sep; 17(9):1143-55. PubMed ID: 16027139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL-21 synergizes with IL-7 to augment expansion and anti-tumor function of cytotoxic T cells.
    Liu S; Lizée G; Lou Y; Liu C; Overwijk WW; Wang G; Hwu P
    Int Immunol; 2007 Oct; 19(10):1213-21. PubMed ID: 17898044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficient generation of survivin-specific cytotoxic T lymphocytes from healthy persons in vitro: quantitative and qualitative effects of CD4+ T cells.
    Kim EK; Cho HI; Yoon SH; Park MJ; Sohn HJ; Kim HJ; Oh ST; Kim TG
    Vaccine; 2008 Jul; 26(32):3987-97. PubMed ID: 18584926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytotoxic T-cell-mediated defense against infections in human liver transplant recipients.
    Tanaka K; Uemoto S; Egawa H; Takada Y; Ozawa K; Teramukai S; Kasahara M; Ogawa K; Ono M; Sato H; Takai K; Fukushima M; Inaba K
    Liver Transpl; 2007 Feb; 13(2):287-93. PubMed ID: 17256783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Specific immune against pancreatic cancer induced by dendritic cells pulsed with mutant K-ras peptide].
    Yang B; He Y; Sun DL; Zou Y; Qin XH; Huang BH
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1956-60. PubMed ID: 19062734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD8+ T cells in autoimmunity.
    Walter U; Santamaria P
    Curr Opin Immunol; 2005 Dec; 17(6):624-31. PubMed ID: 16226438
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective cytotoxic T-lymphocyte targeting of tumor immune escape variants.
    van Hall T; Wolpert EZ; van Veelen P; Laban S; van der Veer M; Roseboom M; Bres S; Grufman P; de Ru A; Meiring H; de Jong A; Franken K; Teixeira A; Valentijn R; Drijfhout JW; Koning F; Camps M; Ossendorp F; Kärre K; Ljunggren HG; Melief CJ; Offringa R
    Nat Med; 2006 Apr; 12(4):417-24. PubMed ID: 16550190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene transfer of AIMP1 and B7.1 into epitope-loaded, fibroblasts induces tumor-specific CTL immunity, and prolongs the survival period of tumor-bearing mice.
    Kim TS; Lee BC; Kim E; Cho D; Cohen EP
    Vaccine; 2008 Nov; 26(47):5928-34. PubMed ID: 18793691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.